Chemed Corporation $CHE Shares Newly Acquired by Advisors Asset Management Inc.

Chemed logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Advisors Asset Management acquired 335,466 Chemed shares in the third quarter, worth approximately $169.4 million. The stake represents about 2.58% of Chemed and is the investor’s third-largest holding.
  • Chemed beat quarterly estimates, reporting EPS of $6.75 versus $6.44 expected and revenue of $690.9 million, up 10.6% year over year.
  • Analysts’ average rating is “Hold,” with an average price target of $603; several firms recently raised their targets or upgraded the stock.
  • MarketBeat previews top five stocks to own in December.

Advisors Asset Management Inc. bought a new stake in Chemed Corporation (NYSE:CHE - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 335,466 shares of the company's stock, valued at approximately $169,434,000. Chemed comprises about 1.5% of Advisors Asset Management Inc.'s holdings, making the stock its 3rd largest position. Advisors Asset Management Inc. owned approximately 2.58% of Chemed as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Richardson Financial Services Inc. lifted its position in Chemed by 5,700.0% during the third quarter. Richardson Financial Services Inc. now owns 58 shares of the company's stock valued at $29,000 after purchasing an additional 57 shares during the period. Fulcrum Asset Management LLP grew its position in Chemed by 121.9% during the 3rd quarter. Fulcrum Asset Management LLP now owns 71 shares of the company's stock worth $36,000 after purchasing an additional 39 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Chemed during the 2nd quarter valued at about $34,000. Versant Capital Management Inc raised its stake in shares of Chemed by 7,500.0% during the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company's stock valued at $35,000 after buying an additional 75 shares during the last quarter. Finally, Keating Financial Advisory Services Inc. purchased a new position in shares of Chemed during the 2nd quarter valued at about $36,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Trading Up 0.9%

Shares of CHE stock opened at $551.41 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.11 and a quick ratio of 1.08. The company has a market cap of $7.18 billion, a price-to-earnings ratio of 23.86, a PEG ratio of 2.08 and a beta of 0.50. The stock has a 50 day simple moving average of $519.43 and a 200-day simple moving average of $469.94. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $562.24.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, October 27th. The company reported $6.75 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.44 by $0.31. Chemed had a net margin of 10.61% and a return on equity of 35.18%. The firm had revenue of $690.94 million for the quarter, compared to analysts' expectations of $685.04 million. During the same quarter last year, the company earned $5.27 EPS. The firm's revenue for the quarter was up 10.6% compared to the same quarter last year. On average, equities research analysts expect that Chemed Corporation will post 24.05 EPS for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Monday, November 16th will be issued a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's dividend payout ratio is presently 13.40%.

Analyst Upgrades and Downgrades

CHE has been the topic of a number of recent research reports. Royal Bank Of Canada upped their target price on Chemed from $548.00 to $585.00 and gave the stock a "sector perform" rating in a research note on Thursday, October 29th. Weiss Ratings upgraded Chemed from a "hold (c)" rating to a "hold (c+)" rating in a research report on Thursday, October 8th. Wall Street Zen upgraded Chemed from a "buy" rating to a "strong-buy" rating in a research report on Saturday, October 10th. Oppenheimer boosted their price target on Chemed from $590.00 to $625.00 and gave the company an "outperform" rating in a report on Thursday, October 29th. Finally, Jefferies Financial Group raised shares of Chemed from a "hold" rating to a "buy" rating and raised their price objective for the stock from $520.00 to $620.00 in a research note on Wednesday, October 28th. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $603.00.

Get Our Latest Analysis on CHE

Insider Activity at Chemed

In other news, CEO Kevin McNamara sold 2,000 shares of the firm's stock in a transaction that occurred on Monday, September 28th. The stock was sold at an average price of $513.45, for a total value of $1,026,900.00. Following the transaction, the chief executive officer owned 66,418 shares in the company, valued at $34,102,322.10. This trade represents a 2.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Spencer Lee sold 1,000 shares of Chemed stock in a transaction that occurred on Wednesday, November 11th. The stock was sold at an average price of $547.61, for a total value of $547,610.00. Following the completion of the sale, the executive vice president directly owned 12,931 shares in the company, valued at $7,081,144.91. This represents a 7.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 7,920 shares of company stock worth $4,147,306. Company insiders own 3.33% of the company's stock.

Chemed Profile

(Free Report)

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines